Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 29:Suppl 4:3.
doi: 10.4172/2161-0932.S4-003.

Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy

Marta Szajnik  1 , Magdalena Derbis  2 , Michal Lach  2 , Paulina Patalas  2 , Marcin Michalak  3 , Hanna Drzewiecka  4 , Dariusz Szpurek  5 , Andrzej Nowakowski  6 , Marek Spaczynski  3 , Włodzimierz Baranowski  6 , Theresa L Whiteside  7
Affiliations

Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy

Marta Szajnik et al. Gynecol Obstet (Sunnyvale). .

Abstract

Background: In patients with Ovarian Cancer (OvCa) exosomes released by tumor cells are present in the plasma and could be involved in tumor progression. This study examines the association between the exosome presence/protein content in plasma of OvCa patients and disease outcome, response to standard therapy and/or tumorresistance to therapies in patients studied at diagnosis and also serially during and after therapy.

Design and methods: Exosomes were purified from OvCa patients' plasma (n=22), patients with benign tumors (n=10) or (n=10) healthy controls (NC) using ultracentrifugation. Exosomes were visualized by scanning electron microscopy. Their protein content was measured. The presence of MAGE 3/6 and TGF-β1 in exosomes was evaluated in Western blots.

Results: The OvCa patients' plasma contained higher levels of exosomal proteins (p<0.05) compared to those isolated from plasma of patients with benign tumors or NC. Exosomes isolated from OvCa patients's plasma carried TGF-β1 and MAGE3/6, which distinguished OvCa patients from those with benign tumors and NC. High protein levels of exosomes were seen in newly diagnosed patients; however in advanced stages of OvCa patients the protein content of isolated exosomes was significantly higher than that of early stages. The exosome levels variably changed during/after chemotherapy, and correlations between the changes in exosomal protein levels and clinical data suggested that the protein content of exosomes might be useful in predicting responses to therapy and prognosis in OvCa patients.

Conclusion: Analysis of plasma exosomes levels offers a novel approach to diagnosis and monitoring response to therapies in OvCa patients.

Keywords: Exosomes; Ovarian carcinoma; Prognosis; Response to therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Quantification and characterization of plasma-derived exosomes in OvCa patients, benign tumor patients and NCA.
Figure 2
Figure 2
Quantative analysis of exosomal proteins in exosomes isolated from plasma of different OvCa patients.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Poole EM, Merritt MA, Jordan SJ, Yang HP, Hankinson SE, et al. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness. Cancer Epidemiol Biomarkers Prev. 2013;22:429–437. - PMC - PubMed
    1. Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 2006;66:3859–3868. - PubMed
    1. Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27:5904–5912. - PMC - PubMed
    1. Czystowska M, Han J, Szczepanski MJ, Szajnik M, Quadrini K, et al. IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death. Cell Death Differ. 2009;16:708–718. - PMC - PubMed
    1. Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, et al. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol. 2009;183:3720–3730. - PMC - PubMed

LinkOut - more resources